Hydrocortisone sodium succinate injection (Solu-Cortef)

Category:

  • Miscellaneous

Description:

  • Anti-inflammatory adrenocortical steroid

Indications:

  • Congenital hyperplasia, bursitis, epicondylitis, ankylosing spondylitis, osteoarthritis

  • Systemic lupus erythematosus, pemphigus, Stevens-Johnson syndrome, exfoliative dermatitis, severe psoriasis, mycosis, fungoides

  • Bronchial asthma, dermatitis, serum sickness, hypersensitivity reacitions, iritis, keratitis

  • Ulcerative colitis, idiopathic thrombocytopenic purpura, erythroblastopenia

Contraindications:

  • Premature infants

  • Systemic fungal infections

Precautions:

  • Pregnancy category

  • Corneal perforation may occur in patients with ocular herpes simplex

  • Psychic derangements may occur

Adverse Reactions (Side Effects):

  • sodium/fluid retention, hypertension, hypokalemic alkalosis, loss of muscle mass

  • aseptic necrosis of femoral/humoral heads, tendon rupture, thin skin, petechiae

  • menstrual irregularities, decreased carbohydrate tolerance, glaucoma, exophthalmos

  • pigmentation changes, negative nitrogen balance

 

Dosage:

Administered intravenously, intramuscularly

  • Initial dose 100mg or 500mg, depending upon severity of the condition; may repeat dose at intervals of 2, 4, or 6 hours as indicated by patient response.  

  • Dose may be reduced in infants and children, but it is governed more by the severity of the condition and response of the patient than by age or body weight but should not be less than 25mg daily.

  • Usual dosage does not extend past 48 to 72 hours.  

  • Prophylactic antacid therapy may be indicated to reduce likelihood of peptic ulceration.

 

Home  ·  Military Medicine  ·  Sick Call  ·  Basic Exams  ·  Medical Procedures  ·  Lab and X-ray  ·  The Pharmacy  ·  The Library  ·  Equipment  ·  Patient Transport  ·  Medical Force Protection  ·  Operational Safety  ·  Operational Settings  ·  Special Operations  ·  Humanitarian Missions  ·  Instructions/Orders  ·  Other Agencies  ·  Video Gallery  ·  Forms  ·  Web Links  ·  Acknowledgements  ·  Help  ·  Feedback

Approved for public release; Distribution is unlimited.

The information contained here is an abbreviated summary. For more detailed and complete information, consult the manufacturer's product information sheets or standard textbooks.

Source: Operational Medicine 2001, Health Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300.

Bureau of Medicine and Surgery
Department of the Navy
2300 E Street NW
Washington, D.C
20372-5300

Operational Medicine
 Health Care in Military Settings
CAPT Michael John Hughey, MC, USNR
NAVMED P-5139
  January 1, 2001

United States Special Operations Command
7701 Tampa Point Blvd.
MacDill AFB, Florida
33621-5323

*This web version is provided by The Brookside Associates, LLC.  It contains original contents from the official US Navy NAVMED P-5139, but has been reformatted for web access and includes advertising and links that were not present in the original version. The medical information presented was reviewed and felt to be accurate in 2001. Medical knowledge and practice methods may have changed since that time. Some links may no longer be active. This web version has not been approved by the Department of the Navy or the Department of Defense. The presence of any advertising on these pages does not constitute an endorsement of that product or service by either the US Department of Defense or the Brookside Associates. The Brookside Associates is a private organization, not affiliated with the United States Department of Defense.

© 2015, Brookside Associates, LLC. All rights reserved

Other Brookside Products

 

 

Advertise on this site